Page last updated: 2024-09-03

nitroflurbiprofen and prednisolone

nitroflurbiprofen has been researched along with prednisolone in 2 studies

Compound Research Comparison

Studies (nitroflurbiprofen)	Trials (nitroflurbiprofen)	Recent Studies (post-2010) (nitroflurbiprofen)	Studies (prednisolone)	Trials (prednisolone)	Recent Studies (post-2010) (prednisolone)
58	1	6	34,414	3,302	7,141

Protein Interaction Comparison

Protein	Taxonomy	prednisolone (IC50)
Glucocorticoid receptor	Homo sapiens (human)	0.0278
Progesterone receptor	Homo sapiens (human)	2.08
Glucocorticoid receptor	Rattus norvegicus (Norway rat)	0.0565
Glycine receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.016
Mineralocorticoid receptor	Homo sapiens (human)	0.0322
Glycine receptor subunit beta	Rattus norvegicus (Norway rat)	0.016
Glycine receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.016
Glycine receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.016

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Swayeh, OA; Keeble, J; Moore, PK	1
Bottinelli, R; Brunelli, S; Clementi, E; Cossu, G; Covarello, D; D'Antona, G; Galvez, BG; Innocenzi, A; Monopoli, A; Ongini, E; Perrotta, C; Sanvito, F; Sciorati, C	1

Other Studies

2 other study(ies) available for nitroflurbiprofen and prednisolone

Article	Year
Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs. British journal of pharmacology, 2001, Volume: 133, Issue:7 Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Blood Pressure; Dose-Response Relationship, Drug; Flurbiprofen; In Vitro Techniques; Kidney; Male; Mesentery; Nitric Oxide; Nitroprusside; Prednisolone; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents	2001
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proceedings of the National Academy of Sciences of the United States of America, 2007, Jan-02, Volume: 104, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Combined Modality Therapy; Creatine Kinase; Flurbiprofen; Mice; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Prednisolone; Regeneration; Sarcoglycans; Stem Cell Transplantation	2007

Article

Year

Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs.

British journal of pharmacology, 2001, Volume: 133, Issue:7

Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Blood Pressure; Dose-Response Relationship, Drug; Flurbiprofen; In Vitro Techniques; Kidney; Male; Mesentery; Nitric Oxide; Nitroprusside; Prednisolone; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents

2001

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Jan-02, Volume: 104, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Combined Modality Therapy; Creatine Kinase; Flurbiprofen; Mice; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Prednisolone; Regeneration; Sarcoglycans; Stem Cell Transplantation

2007